Page last updated: 2024-09-05

sb 203580 and Kidney Tubular Transport, Inborn Error

sb 203580 has been researched along with Kidney Tubular Transport, Inborn Error in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, Y; Kasamatsu, A; Kita, A; Koike, K; Nakashima, D; Saito, T; Sawai, Y; Shiiba, M; Takiguchi, Y; Tanzawa, H; Toeda, Y; Uzawa, K1

Other Studies

1 other study(ies) available for sb 203580 and Kidney Tubular Transport, Inborn Error

ArticleYear
Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.
    Experimental cell research, 2019, 03-15, Volume: 376, Issue:2

    Topics: Animals; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Therapy, Combination; ErbB Receptors; Exanthema; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Growth Inhibitors; HEK293 Cells; Humans; Hypercalciuria; Imidazoles; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Nephrocalcinosis; Pyridines; Renal Tubular Transport, Inborn Errors; Transcriptome; Xenograft Model Antitumor Assays

2019